首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >A COMPARATIVE STUDY OF ANTI-ANGIOGENIC ACTIVITIES OF MEDICINAL PLANTS AND ITS THERAPEUTIC POTENTIAL IN ANGIOGENESIS-DEPENDENT DISORDERS
【24h】

A COMPARATIVE STUDY OF ANTI-ANGIOGENIC ACTIVITIES OF MEDICINAL PLANTS AND ITS THERAPEUTIC POTENTIAL IN ANGIOGENESIS-DEPENDENT DISORDERS

机译:血管生成相关疾病中药用植物抗血管活性及其治疗潜能的比较研究

获取原文
获取外文期刊封面目录资料

摘要

IntroductionAngiogenesis, the process of new vessel growth from pre-existing capillaries is involved in physiological and pathological process such as embryonic development, wound healing, diabetic retinopathy ,chronic inflammation, tumor growth and metastasis. Vascular endothelial growth factor (VEGF) induced angiogenesis plays an important role in the pathogenesis of diabetic retinopathy and cancer and anti VEGF factor agents are found to be effective . VEGF inhibitors from plant sources show promising result recently. So this study is designed to evaluate and compare the VEGF inhibitory effect of the herbs Osimum Sanctum, Andrographis paniculata, Syzygium cumini and Ginkgo biloba by using in vivo models.Methods: Both Corneal neovascularization assay and Chick Chorioallantoic membrane assays were used for evaluation. The induced neovascularization was compared with control and extract treated groups.Results: The acute and repeated dose toxicity tests showed that the extracts are safe on oral administration. And also the results showed significant antiangiogenic effect of individual extract and their combination in both in vivo models. However the combination of the extract showed excellent result (p <0.001) by reducing neovascularization in both modelsConclusion: The above results suggested that combination of the above extracts have promising future in the management of angiogenesis dependent disorders.
机译:引言血管生成是由先前存在的毛细血管引起的新血管生长过程,涉及生理和病理过程,例如胚胎发育,伤口愈合,糖尿病性视网膜病,慢性炎症,肿瘤生长和转移。血管内皮生长因子(VEGF)诱导的血管生成在糖尿病性视网膜病变的发病机理中起着重要作用,并且发现癌症和抗VEGF因子药物是有效的。来自植物的VEGF抑制剂最近显示出有希望的结果。因此,本研究旨在通过体内模型评估和比较草药(Osimum Sanctum),穿心莲(Andrographis paniculata),孜然(Syzygium cumini)和银杏(Ginkgo biloba)对VEGF的抑制作用。将诱导的新血管形成与对照组和提取物治疗组进行比较。结果:急性和反复剂量毒性试验表明,提取物口服安全。结果还表明,在两种体内模型中,单个提取物及其组合均具有显着的抗血管生成作用。然而,在两种模型中,提取物的组合均通过减少新血管形成而显示了极好的结果(p <0.001)结论:以上结果表明,上述提取物的组合在血管生成依赖性疾病的治疗方面具有广阔的前景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号